Skip to main content

Increased #Mortality Rates During the 2025 #Chikungunya #Epidemic in #Réunion Island

Image
By G.M.

 


Abstract

Background: 

Chikungunya virus (CHIKV) has historically been regarded as a low-fatality infection; however, growing evidence from diverse study designs demonstrated a substantial mortality burden during large-scale epidemics. In 2025, Réunion Island experienced a major CHIKV outbreak, raising renewed concerns about its fatal impact. 

Methods: 

We conducted an ecological time-series analysis of all-cause mortality during the 2025 chikungunya epidemic. Expected deaths were estimated using two complementary approaches: (i) a baseline based on age-specific mean mortality rates from the same calendar months in the post-pandemic period and (ii) long-term Poisson regression models using a log-link function and population offset, excluding the COVID-19 pandemic period. Excess mortality was calculated as the difference between observed and expected deaths during periods when observed mortality significantly exceeded the upper bound of the 95% confidence interval. 

Results: 

Observed mortality exceeded the upper 95% confidence interval (CI) limit for three consecutive months, coinciding with the epidemic curve and resulting in an estimated 208 excess deaths. These deaths were concentrated among older adults, peaking in April 2025 with a mortality rate ratio of 1.34 (95% CI: 1.22–1.47; p < 0.001). Among older adults, the age-specific excess mortality rate reached 145.3 per 100,000 (95% CI: 125.5–165.0) with a case fatality rate (CFR) of 2.4%, resulting in an overall population excess mortality rate of 23.2 per 100,000 and a total CFR of 0.4%. The number of deaths identified through routine surveillance was substantially lower than our estimates, highlighting a significant discrepancy between reported and excess chikungunya-associated mortality. 

Conclusions: 

Chikungunya epidemics are consistently associated with substantial underrecognized mortality worldwide. Routine surveillance relying solely on laboratory confirmation underestimates the true burden of the disease. Integrating excess mortality analysis, strengthening diagnostic and postmortem investigations, and implementing timely mitigation measures are essential to accurately assess and reduce preventable deaths during future CHIKV outbreaks.

Source: 


Link: https://www.mdpi.com/1999-4915/18/2/180

____

Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »